NL-OMON50418
Completed
Not Applicable
MOlecular stool testing for Colorectal CAncer Surveillance - MOCCAS
Antoni van Leeuwenhoek Ziekenhuis0 sites4,000 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- colorectal carcinoma
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 4000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Subjects in the age group 50\-75 years.
- •\- Subjects with an indication for surveillance colonoscopy according to the
- •previous guideline (\*Follow up after polypectomy\*, 2002; summarized in 2008\) or
- •current (\*Colonoscopy Surveillance\*, 2013\) guideline, i.e. subjects with a
- •history of CRC or polypectomy, as well as subjects under surveillance for
- •familial colorectal carcinoma (FCC).
- •\- Subjects who have sufficient comprehension of the Dutch language.
- •\- Subjects who have given their informed consent.
Exclusion Criteria
- •\- Subjects with inflammatory bowel disease (IBD)
- •\- Subjects with Lynch syndrome, familial adenomatous polyposis (FAP),
- •attenuated FAP (AFAP), MUTYH associated polyposis (MAP) and serrated polyposis
- •syndrome (SPS)
- •\- Subjects with a previous colonoscopy \< 6 months (rescopy)
- •\- Subjects with proctocolectomy
- •\- Subjects with life expectancy \< 3 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Molecular stool testing for colorectal cancer surveillancecolorectal cancer, surveillance, molecular stool testingcolorectaal carcinoom, surveillance, moleculaire ontlastingstestNL-OMON26772prof. dr. P. FockensMeibergdreef 9, room C2-3301105 AZ Amsterdam, the Netherlandsemail: p.fockens@amc.uva.nltel: +31 20 56634084,000
Completed
Not Applicable
Screening for Colorectal Cancer in Recipients of Kidney TransplantsKidney Transplantation - post transplant malignancyColorectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12608000154303Dr Michael Collins450
Completed
Not Applicable
Estimating uptake of colorectal cancer screening testsTopic: Primary Care Research Network for England / Colorectal cancer screeningCancerMalignant neoplasm of colon and rectumISRCTN85697880CL/UCLH/Royal Free Biomedical Research Unit (UK)3,040
Completed
Not Applicable
The novel diagnostic method of colorectal cancer by methyl mercaptaThe novel diagnostic method for colorectal cancer: Detection of methyl-mercaptan from flatus.JPRN-UMIN000028256Yokohama City University50
Recruiting
Not Applicable
Molecular diagnositcs of colon cancerKCT0002703MD Healthcare350